Risk factor
Strong & resilient to price shocks
Profitability factor
Very strong margins and returns
About
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut...
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'expensive' on E
Target Price
The average target price of BIOG-B.ST is 140 and suggests 27% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in
Buy
Sell